Solstice Neurosciences, LLC
Records under this name other than patents Solstice Neurosciences, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Solstice Neurosciences, LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,173,138 | Stable liquid formulations of botulinum toxin Lapsed on the fee record Ended May 8, 2020 · From the USPTO record | Lapsed on the fee record | Ended May 8, 2020 | From the USPTO record |
| US 6,290,961 | Method for treating dystonia with botulinum toxin type B Term ended Term ended Jan 24, 2020 · From the USPTO record | Term ended | Term ended Jan 24, 2020 | From the USPTO record |
| US 7,211,261 | Stable liquid formulations of botulinum toxin Term ended Term ended Sep 9, 2019 · From the USPTO record | Term ended | Term ended Sep 9, 2019 | From the USPTO record |
| US 6,011,761 | Downloading compressed audio data from a server and detecting recording inhibiting information Term ended Term ended Jun 19, 2018 · From the USPTO record | Term ended | Term ended Jun 19, 2018 | From the USPTO record |
| US 6,887,476 | Method for treating pain with botulinum toxin type B Term ended Term ended Mar 30, 2015 · From the USPTO record | Term ended | Term ended Mar 30, 2015 | From the USPTO record |
| US 6,645,496 | Method for treating tardive dyskinesia with Botulinum toxin type B Term ended Ended no later than Mar 29, 2015 · From the USPTO record | Term ended | Ended no later than Mar 29, 2015 | From the USPTO record |
| US 6,861,058 | Method for treating essential tremor with botulinum toxin type B Term ended Term ended Mar 16, 2015 · From the USPTO record | Term ended | Term ended Mar 16, 2015 | From the USPTO record |
| US 6,841,156 | Method for treating muscle spasm with botulinum toxin type B Term ended Term ended Apr 24, 2014 · From the USPTO record | Term ended | Term ended Apr 24, 2014 | From the USPTO record |
| US 6,632,433 | Method for treating cervical dystonia with botulinum toxin type B Term ended Ended no later than Feb 18, 2014 · From the USPTO record | Term ended | Ended no later than Feb 18, 2014 | From the USPTO record |
| US 6,872,397 | Method for treating neuromuscular disorders and conditions with botulinum toxin types A and B Term ended Term ended Jun 10, 2013 · From the USPTO record | Term ended | Term ended Jun 10, 2013 | From the USPTO record |